Literature DB >> 2606096

Adjusting energy expenditure for body weight in early infancy.

P S Davies1, T J Cole, A Lucas.   

Abstract

The most appropriate method of expressing energy expenditure relative to body weight was investigated in 50 normal, full-term infants at 6 weeks, 12 weeks and 6 months of age. Regression analysis revealed that the relationship between body weight and energy expenditure at each age could be adjusted for by expressing energy expenditure per kg0.65, per kg0.43 and per kg0.55 body weight at the three age points studied. These powers were not significantly different and a pooled estimate was per kg0.56. This is very close to kg0.5 or the square root of body weight. It is suggested that in studies on energy, metabolism in early infancy the expression of total energy expenditure per kg0.5 body weight should be used as the most appropriate adjustment for removing the influence of body weight upon energy expenditure.

Entities:  

Mesh:

Year:  1989        PMID: 2606096

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  4 in total

1.  Total energy expenditure in small for gestational age infants.

Authors:  P S Davies; H Clough; N J Bishop; A Lucas; J J Cole; T J Cole
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-07       Impact factor: 5.747

2.  Total energy expenditure in small for gestational age infants.

Authors:  P S Davies; H Clough; N J Bishop; A Lucas; J J Cole; T J Cole
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-05       Impact factor: 5.747

Review 3.  Normalisation of anti-cancer drug dosage using body weight and surface area: is it worthwhile? A review of theoretical and practical considerations.

Authors:  J J Reilly; P Workman
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

4.  Energy expenditure in congenital heart disease.

Authors:  J S Barton; P C Hindmarsh; C M Scrimgeour; M J Rennie; M A Preece
Journal:  Arch Dis Child       Date:  1994-01       Impact factor: 3.791

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.